[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$canta

Cantargia's TRIFOUR trial results are out, with Redeye commenting on the negative topline data. FrillePelle and Redeye are providing commentary on the data and the company's future.

About $canta

Cantargia ($canta) is a biotechnology company.

Insights #

$canta mentions is at XX which is XXXXX% higher than it's daily average.
$canta mentions near a 52-week high at XX.
$canta creators is at XX which is XXX% higher than it's daily average.
$canta creators is up XXXXXX% from the previous month.
$canta engagements is up XXXXXXXX% from the previous week.
$canta mentions is up XXXXXXXX% from the previous week.
$canta posts created is up XXX% from the previous month.
$canta Mentions hit a high of XX for the day
$canta Mentions hit an all time of XX for the day
$canta Creators hit a high of XX for the day
$canta Creators hit an all time of XX for the day

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXX
1 Week: XXXXX +1,528%
1 Month: XXXXXX +473%
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-05-09

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XXX +1,357%
1 Month: XXX +1,225%
1-Year High: XX on 2025-07-23
1-Year Low: X on 2025-04-27

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $canta in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
1 Week: XX +140%
1 Month: XX +333%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-04-27

The most influential creators that mention $canta in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@FrillePelle	X	XXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1-Year High: XXX% on 2025-07-03
1-Year Low: XX% on 2025-07-20

Most Supportive Themes

Positive Developments: (75%) Positive commentary on the potential of Nadunolimab and Cantargia's programs.

Most Critical Themes

Negative Trial Results: (25%) Negative topline data from the TRIFOUR study.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXX	XX%	XX	X%

Total	XXX	XX%	XXX	XX%	XX	X%

Top assets mentioned In the posts about $canta in the last XX hours

AbbVie Inc (ABBV) Scholar Rock Holding Corporation Common Stock (SRRK) Immunogen Inc (IMGN) Pfizer, Inc. (PFE) Ellipsis (EPS) Lantheus Holdings, Inc (LNTH)

Top topics mentioned In the posts about $canta in the last XX hours

stocks healthcare, $4768t, $4578t, investment, discussions, $abbv, abus, $lenz, $ghrs, $fna, $phat, $rgnx, $siga, $urgn, $crbp, $aplt, $cdmo, $oric, $repl, $lxrx, $abvx, $adpt, $tvtx, $cuv, $abus, $eras, $meso, $avbp, $stok, $crgx, $zyme, $pahc, $ontx, $svra, $wve, $cvac, $nuvb, $auph, $ctkb, $icpt, $plrx, $srrk, generated, rates, dag, $imgn, $pfe, $580m, $33m, acquisition, eps, $eps, coins defi, beta, att, ssc, breakthrough, alot, har, virtual, cart, kan, gns, $xbit, $lnth, stocks defense, abstract, frn, correlation, checkpoint, holders